Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 7, 2018

View Archived Issues

Study gives clues to mitigating pneumonia risk after flu

Structural tuning yields tuberculosis fighter

CRISPR bad news, but with a fix

Crunching the data on CRP

Silencing SOD1 with miRNA for SOD1-linked ALS

New insights into microexon regulation

Fat and fibroblasts

GlycoMimetics initiates phase III trial of uproleselan in relapsed/refractory AML

YC-6 exhibits safety and tolerability in first-in-human study

Deubiquitinase Usp12 is neuroprotective in Huntington's disease neurons

Discovery of new envelope-based antigen that triggers potent humoral responses against HIV-1

INS-3001 demonstrates efficacy in rat model of vascular calcifications

Enesi and Sementis collaborate on solid dose vaccine development

Corcept Therapeutics enrolling participants in phase III study of relacorilant

CF-MEV-132 reduces lung damage in rat model of hyperoxia-induced bronchopulmonary dysplasia

Platelet-targeting vaccine may reduce post-stroke blood clot risk

MC-RG19, a novel 5-HT7 receptor antagonist, reduces hypothermia in rats

Upadacitinib demonstrates efficacy in treating ulcerative colitis

Universita di Pisa patents AMPK subunit alpha-2 activators

Novintum Biotechnology presents new doxycycline derivatives for cancer

FDA clears IND for herpes zoster vaccine candidate CRV-101

FDA approves Empliciti plus pomalidomide and dexamethasone for relapsed/refractory multiple myeloma

DSMB recommends discontinuation of phase III study of PREOB for osteonecrosis

Secarna and MetP to codevelop transnasal antisense oligonucleotide-based CNS therapeutics

Sosei collaborates with DyNAbind to accelerate GPCR drug discovery

Tonix presents retrospective analyses from phase III HONOR study of Tonmya in PTSD

BioNTech and University of Pennsylvania collaborate on mRNA-based vaccines for infectious disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...